Capital Advisors Inc. OK Grows Stock Holdings in Stryker Corporation $SYK

Capital Advisors Inc. OK grew its stake in Stryker Corporation (NYSE:SYK) by 6.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 164,288 shares of the medical technology company’s stock after purchasing an additional 9,257 shares during the period. Capital Advisors Inc. OK’s holdings in Stryker were worth $60,732,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of Stryker in the 2nd quarter worth $26,000. Clayton Financial Group LLC purchased a new stake in shares of Stryker in the third quarter valued at about $26,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Stryker in the second quarter valued at about $28,000. Sachetta LLC increased its position in Stryker by 58.7% during the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares during the last quarter. Finally, Kilter Group LLC purchased a new position in Stryker during the second quarter worth about $29,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Activity

In related news, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the completion of the transaction, the chief financial officer owned 6,694 shares in the company, valued at approximately $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO William E. Berry, Jr. sold 1,953 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares in the company, valued at approximately $1,035,433.17. The trade was a 40.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 522,118 shares of company stock valued at $185,381,932. 5.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SYK. Needham & Company LLC reissued a “buy” rating and issued a $448.00 price target on shares of Stryker in a research note on Friday, November 14th. Redburn Partners set a $420.00 price objective on Stryker in a research report on Thursday, September 18th. Evercore ISI cut their target price on Stryker from $410.00 to $405.00 and set an “outperform” rating for the company in a research note on Friday, October 31st. Rothschild & Co Redburn initiated coverage on Stryker in a research report on Thursday, September 18th. They issued a “neutral” rating and a $420.00 target price on the stock. Finally, Citigroup decreased their price target on Stryker from $455.00 to $420.00 and set a “buy” rating on the stock in a research note on Thursday, December 11th. Thirteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $431.84.

Stryker Stock Down 1.0%

NYSE:SYK opened at $348.12 on Friday. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19. The stock’s fifty day moving average is $360.63 and its two-hundred day moving average is $375.57. The stock has a market capitalization of $133.13 billion, a price-to-earnings ratio of 45.74, a price-to-earnings-growth ratio of 2.23 and a beta of 0.89. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The firm had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. During the same quarter in the previous year, the business earned $2.87 EPS. The company’s quarterly revenue was up 10.2% compared to the same quarter last year. Research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.88 per share. This is a boost from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, December 31st. Stryker’s dividend payout ratio is currently 46.25%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.